Delayed administration of guanosine improves long‑term functional recovery and enhances neurogenesis and angiogenesis in a mouse model of photothrombotic stroke

Deng,Gang; Qiu,Zhandong; Li,Dayong; Fang,Yu; Zhang,Suming

doi:10.3892/mmr.2017.6521

Delayed administration of guanosine improves long‑term functional recovery and enhances neurogenesis and angiogenesis in a mouse model of photothrombotic stroke

Authors:
- Gang Deng
- Zhandong Qiu
- Dayong Li
- Yu Fang
- Suming Zhang
View Affiliations

Affiliations: Department of Neurology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430030, P.R. China
Published online on: April 27, 2017 https://doi.org/10.3892/mmr.2017.6521
Pages: 3999-4004
Copyright: © Deng et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Guanosine (GUO) is neuroprotective when administered acutely for the treatment of cerebral ischemia. The aim of the present study was to investigate whether delayed administration of GUO improved long‑term functional recovery following stroke, as well as to explore the potential underlying mechanisms. GUO (8 mg/kg) or a vehicle was administered intraperitoneally for 7 consecutive days beginning 24 h prior to photothrombosis‑induced stroke in male C57/B6J mice. Behaviour tests were performed at days 1, 3, 7, 14 and 28 post‑stroke. Infarct volume was measured using Nissl staining at day 7 post‑stroke. Neurogenesis and angiogenesis were evaluated by co‑labelling bromodeoxyuridine (BrdU) with doublecortin (DCX), neuronal nuclei (NeuN) and von Willebrand factor, in immunohistochemical studies. Brain‑derived neurotrophic factor (BDNF) and vascular endothelial growth factor (VEGF) levels in the ipsilesional brain at day 28 post‑stroke were detected by western blot analysis. Delayed administration of GUO did not reduce infarct volume or affect neurological function at day 7 post‑stroke; however, it did improve functional recovery from day 14 post‑stroke, when compared with the vehicle group. GUO significantly increased the number of BrdU+ and BrdU+/DCX+ cells in the subventricular zone and subgranular zone at all examined time points, the number of Brdu+/NeuN+ cells in the peri‑infarction region at days 14 and 28 post‑stroke and microvessel density in the peri‑infarction region at day 28 post‑stroke compared with the vehicle group. In addition, the BDNF and VEGF levels in the ipsilesional brain were significantly elevated. Delayed administration of GUO at 24 h post‑stroke enhanced neurogenesis and angiogenesis, and increased BDNF and VEGF levels, which likely contributes to long‑term functional recovery following stroke.

View Figures

View References

1	Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Ahn SY, et al: Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet. 380:2095–2128. 2012. View Article : Google Scholar
2	Lackland DT, Roccella EJ, Deutsch AF, Fornage M, George MG, Howard G, Kissela BM, Kittner SJ, Lichtman JH, Lisabeth LD, et al: Factors influencing the decline in stroke mortality: A statement from the American Heart Association/American Stroke Association. Stroke. 45:315–353. 2014. View Article : Google Scholar
3	Adams HP Jr, Adams RJ, Brott T, del Zoppo GJ, Furlan A, Goldstein LB, Grubb RL, Higashida R, Kidwell C, Kwiatkowski TG, et al: Guidelines for the early management of patients with ischemic stroke: A scientific statement from the Stroke Council of the American Stroke Association. Stroke. 34:1056–1083. 2003. View Article : Google Scholar
4	Hermann DM and Chopp M: Promoting brain remodelling and plasticity for stroke recovery: Therapeutic promise and potential pitfalls of clinical translation. Lancet Neurol. 11:369–380. 2012. View Article : Google Scholar :
5	Ming GL and Song H: Adult neurogenesis in the mammalian central nervous system. Annu Rev Neurosci. 28:223–250. 2005. View Article : Google Scholar
6	Liu J, Wang Y, Akamatsu Y, Lee CC, Stetler RA, Lawton MT and Yang GY: Vascular remodeling after ischemic stroke: Mechanisms and therapeutic potentials. Prog Neurobiol. 115:138–156. 2014. View Article : Google Scholar
7	Schmidt AP, Lara DR and Souza DO: Proposal of a guanine-based purinergic system in the mammalian central nervous system. Pharmacol Ther. 116:401–416. 2007. View Article : Google Scholar
8	Lanznaster D, Dal-Cim T, Piermartiri TC and Tasca CI: Guanosine: A neuromodulator with therapeutic potential in brain disorders. Aging Dis. 7:657–679. 2016. View Article : Google Scholar :
9	Uemura Y, Miller JM, Matson WR and Beal MF: Neurochemical analysis of focal ischemia in rats. Stroke. 22:1548–1553. 1991. View Article : Google Scholar
10	Chang R, Algird A, Bau C, Rathbone MP and Jiang S: Neuroprotective effects of guanosine on stroke models in vitro and in vivo. Neurosci Lett. 431:101–105. 2008. View Article : Google Scholar
11	Rathbone MP, Saleh TM, Connell BJ, Chang R, Su C, Worley B, Kim M and Jiang S: Systemic administration of guanosine promotes functional and histological improvement following an ischemic stroke in rats. Brain Res. 1407:79–89. 2011. View Article : Google Scholar
12	Connell BJ, Di Iorio P, Sayeed I, Ballerini P, Saleh MC, Giuliani P, Saleh TM, Rathbone MP, Su C and Jiang S: Guanosine protects against reperfusion injury in rat brains after ischemic stroke. J Neurosci Res. 91:262–272. 2013. View Article : Google Scholar
13	Hansel G, Ramos DB, Delgado CA, Souza DG, Almeida RF, Portela LV, Quincozes-Santos A and Souza DO: The potential therapeutic effect of guanosine after cortical focal ischemia in rats. PLoS One. 9:e906932014. View Article : Google Scholar :
14	Hansel G, Tonon AC, Guella FL, Pettenuzzo LF, Duarte T, Duarte MM, Oses JP, Achaval M and Souza DO: Guanosine protects against cortical focal ischemia. Involvement of inflammatory response. Mol Neurobiol. 52:1791–1803. 2015. View Article : Google Scholar
15	Gysbers JW and Rathbone MP: GTP and guanosine synergistically enhance NGF-induced neurite outgrowth from PC12 cells. Int J Dev Neurosci. 14:19–34. 1996. View Article : Google Scholar
16	Su C, Wang P, Jiang C, Ballerini P, Caciagli F, Rathbone MP and Jiang S: Guanosine promotes proliferation of neural stem cells through cAMP-CREB pathway. J Biol Regul Homeost Agents. 27:673–680. 2013.
17	Jiang S, Khan MI, Lu Y, Wang J, Buttigieg J, Werstiuk ES, Ciccarelli R, Caciagli F and Rathbone MP: Guanosine promotes myelination and functional recovery in chronic spinal injury. Neuroreport. 14:2463–2467. 2003. View Article : Google Scholar
18	Gerrikagoitia I and Martínez-Millán L: Guanosine-induced synaptogenesis in the adult brain in vivo. Anat Rec (Hoboken). 292:1968–1975. 2009. View Article : Google Scholar
19	Jang JY, Choi YW, Kim HN, Kim YR, Hong JW, Bae DW, Park SJ, Shin HK and Choi BT: Neuroprotective effects of a novel single compound 1-methoxyoctadecan-1-ol isolated from Uncaria sinensis in primary cortical neurons and a photothrombotic ischemia model. PLoS One. 9:e853222014. View Article : Google Scholar :
20	Chen J, Sanberg PR, Li Y, Wang L, Lu M, Willing AE, Sanchez-Ramos J and Chopp M: Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats. Stroke. 32:2682–2688. 2001. View Article : Google Scholar
21	Clarkson AN, Overman JJ, Zhong S, Mueller R, Lynch G and Carmichael ST: AMPA receptor-induced local brain-derived neurotrophic factor signaling mediates motor recovery after stroke. J Neurosci. 31:3766–3775. 2011. View Article : Google Scholar :
22	de Vasconcelos Dos Santos A, da Costa Reis J, Paredes B Diaz, Moraes L, Jasmin, Giraldi-Guimarães A and Mendez-Otero R: Therapeutic window for treatment of cortical ischemia with bone marrow-derived cells in rats. Brain Res. 1306:149–158. 2010. View Article : Google Scholar
23	Thomazi AP, Boff B, Pires TD, Godinho G, Battú CE, Gottfried C, Souza DO, Salbego C and Wofchuk ST: Profile of glutamate uptake and cellular viability in hippocampal slices exposed to oxygen and glucose deprivation: Developmental aspects and protection by guanosine. Brain Res. 1188:233–240. 2008. View Article : Google Scholar
24	Su C, Elfeki N, Ballerini P, D'Alimonte I, Bau C, Ciccarelli R, Caciagli F, Gabriele J and Jiang S: Guanosine improves motor behavior, reduces apoptosis, and stimulates neurogenesis in rats with parkinsonism. J Neurosci Res. 87:617–625. 2009. View Article : Google Scholar
25	Lichtenwalner RJ and Parent JM: Adult neurogenesis and the ischemic forebrain. J Cereb Blood Flow Metab. 26:1–20. 2006. View Article : Google Scholar
26	Zhao C, Deng W and Gage FH: Mechanisms and functional implications of adult neurogenesis. Cell. 132:645–660. 2008. View Article : Google Scholar
27	Rathbone MP, Middlemiss PJ, Gysbers JW, Andrew C, Herman MA, Reed JK, Ciccarelli R, Di Iorio P and Caciagli F: Trophic effects of purines in neurons and glial cells. Prog Neurobiol. 59:663–690. 1999. View Article : Google Scholar
28	Schabitz WR, Steigleder T, Cooper-Kuhn CM, Schwab S, Sommer C, Schneider A and Kuhn HG: Intravenous brain-derived neurotrophic factor enhances poststroke sensorimotor recovery and stimulates neurogenesis. Stroke. 38:2165–2172. 2007. View Article : Google Scholar
29	Jin K, Zhu Y, Sun Y, Mao XO, Xie L and Greenberg DA: Vascular endothelial growth factor (VEGF) stimulates neurogenesis in vitro and in vivo. Proc Natl Acad Sci USA. 99:pp. 11946–11950. 2002; View Article : Google Scholar :
30	Hermann DM and Zechariah A: Implications of vascular endothelial growth factor for postischemic neurovascular remodeling. J Cereb Blood Flow Metab. 29:1620–1643. 2009. View Article : Google Scholar